These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20610525)

  • 21. Octreotide-induced hyperkalemia.
    Sargent AI; Overton CC; Kuwik RJ; Varcelotti JR; Deppe SA
    Pharmacotherapy; 1994; 14(4):497-501. PubMed ID: 7937289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrocardiography is unreliable in detecting potentially lethal hyperkalaemia in haemodialysis patients.
    Aslam S; Friedman EA; Ifudu O
    Nephrol Dial Transplant; 2002 Sep; 17(9):1639-42. PubMed ID: 12198216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-induced disorders of glucose metabolism. Mechanisms and management.
    Chan JC; Cockram CS; Critchley JA
    Drug Saf; 1996 Aug; 15(2):135-57. PubMed ID: 8884164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of octreotide in the treatment of hypoglycemia induced by sulfonylureas].
    Clerc D; Hugli O; Trueb L; Yersin B
    Rev Med Suisse; 2008 Aug; 4(167):1764-7. PubMed ID: 18800755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Octreotide in children with hypoglycaemia due to sulfonylurea ingestion.
    Rath S; Bar-Zeev N; Anderson K; Fahy R; Roseby R
    J Paediatr Child Health; 2008 Jun; 44(6):383-4. PubMed ID: 18476935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of aminophylline and insulin-dextrose infusions in acute therapy of hyperkalemia in end-stage renal disease patients.
    Mahajan SK; Mangla M; Kishore K
    J Assoc Physicians India; 2001 Nov; 49():1082-5. PubMed ID: 11868861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine.
    Rolleman EJ; Valkema R; de Jong M; Kooij PP; Krenning EP
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):9-15. PubMed ID: 12483404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of octreotide acetate to prevent rebound hypoglycaemia in sulfonylurea overdose.
    Hassan Z; Wright J
    Emerg Med J; 2007 Aug; 24(8):580-1. PubMed ID: 17652687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of severe refractory sulfonylurea-induced hypoglycemia with octreotide.
    Krentz AJ; Boyle PJ; Justice KM; Wright AD; Schade DS
    Diabetes Care; 1993 Jan; 16(1):184-6. PubMed ID: 8422773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia.
    Fasano CJ; O'Malley G; Dominici P; Aguilera E; Latta DR
    Ann Emerg Med; 2008 Apr; 51(4):400-6. PubMed ID: 17764782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches.
    Ngugi NN; McLigeyo SO; Kayima JK
    East Afr Med J; 1997 Aug; 74(8):503-9. PubMed ID: 9487416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of octreotide in a case of refractory sulfonylurea-induced hypoglycemia.
    Green RS; Palatnick W
    J Emerg Med; 2003 Oct; 25(3):283-7. PubMed ID: 14585456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of fludrocortisone acetate on reducing serum potassium levels in patients with end-stage renal disease undergoing haemodialysis.
    Kim DM; Chung JH; Yoon SH; Kim HL
    Nephrol Dial Transplant; 2007 Nov; 22(11):3273-6. PubMed ID: 17616536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refractory Hypoglycemia Due to Sulfonylurea Contamination of Illicit Opioid Medications.
    Savarino JR; Mokszycki R; Tubbs R; Wightman RS
    R I Med J (2013); 2024 May; 107(5):11-13. PubMed ID: 38687261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Haemodialysis during resuscitation from hyperkalemic cardiac arrest].
    Iwańczuk W
    Anestezjol Intens Ter; 2008; 40(3):169-72. PubMed ID: 19469118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Refractory hyperkalaemia associated with use of epsilon-aminocaproic acid during coronary bypass in a dialysis patient.
    Nzerue CM; Falana B
    Nephrol Dial Transplant; 2002 Jun; 17(6):1150-1. PubMed ID: 12032221
    [No Abstract]   [Full Text] [Related]  

  • 37. Indomethacin-induced hyperkalaemia.
    MacCarthy EP; Frost GW; Strokes GS
    Med J Aust; 1979 Jun; 1(12):550. PubMed ID: 470726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hyperkalemia during prolonged use of angiotensin II-converting enzyme inhibitors in end-stage renal insufficiency].
    Mooser V; Fellay G; Regamey C
    Schweiz Med Wochenschr; 1992 Dec; 122(50):1927-9. PubMed ID: 1465596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Octreotide for the treatment of hypoglycemia after insulin glargine overdose.
    Groth CM; Banzon ER
    J Emerg Med; 2013 Aug; 45(2):194-8. PubMed ID: 23669130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Octreotide's role in the management of sulfonylurea-induced hypoglycemia.
    Dougherty PP; Klein-Schwartz W
    J Med Toxicol; 2010 Jun; 6(2):199-206. PubMed ID: 20352540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.